Works matching IS 00071048 AND DT 2024 AND VI 205 AND IP 3
Results: 59
Molecular monitoring of myelodysplastic neoplasm: Don't just watch this space, consider the patient's ancestry.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 759, doi. 10.1111/bjh.19689
- By:
- Publication type:
- Article
Could machine learning revolutionize how we treat immune thrombocytopenia?
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 770, doi. 10.1111/bjh.19684
- By:
- Publication type:
- Article
Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1180, doi. 10.1111/bjh.19681
- By:
- Publication type:
- Article
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1017, doi. 10.1111/bjh.19680
- By:
- Publication type:
- Article
Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1055, doi. 10.1111/bjh.19679
- By:
- Publication type:
- Article
Risk‐adapted treatment in multiple myeloma: Does more make it merrier?
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 767, doi. 10.1111/bjh.19676
- By:
- Publication type:
- Article
Mitigating infection risks: The promise and challenge of bispecific antibodies in haematological malignancies.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 764, doi. 10.1111/bjh.19668
- By:
- Publication type:
- Article
Bloomsbury, Belsen, Oxford: Janet Vaughan— Medical Pioneer.
- Published in:
- 2024
- By:
- Publication type:
- Book Review
Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 823, doi. 10.1111/bjh.19657
- By:
- Publication type:
- Article
Emergency myelopoiesis in solid cancers.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 798, doi. 10.1111/bjh.19656
- By:
- Publication type:
- Article
Rolling the DICEP on lymphoma salvage treatments? Choose wisely.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 761, doi. 10.1111/bjh.19655
- By:
- Publication type:
- Article
Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1097, doi. 10.1111/bjh.19651
- By:
- Publication type:
- Article
Prevention and management of indwelling catheter‐related thrombosis in sickle cell disease and thalassaemia: A British Society for Haematology Good Practice Paper.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 840, doi. 10.1111/bjh.19650
- By:
- Publication type:
- Article
Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1126, doi. 10.1111/bjh.19649
- By:
- Publication type:
- Article
Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1170, doi. 10.1111/bjh.19648
- By:
- Publication type:
- Article
Molecular monitoring of MDS: Watch this space!
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 757, doi. 10.1111/bjh.19644
- By:
- Publication type:
- Article
Cognitive outcomes of children and adults with sickle cell anaemia: A contemporary cohort.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1238, doi. 10.1111/bjh.19642
- By:
- Publication type:
- Article
Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAF<sup>V600E</sup> clone in a newborn affected by high‐risk Langerhans cell histiocytosis.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1234, doi. 10.1111/bjh.19637
- By:
- Publication type:
- Article
Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1159, doi. 10.1111/bjh.19636
- By:
- Publication type:
- Article
Guidelines on the investigation and management of antiphospholipid syndrome.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 855, doi. 10.1111/bjh.19635
- By:
- Publication type:
- Article
Outcomes of infants with very late relapse of acute lymphoblastic leukaemia initially treated in Interfant‐06.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1230, doi. 10.1111/bjh.19634
- By:
- Publication type:
- Article
Diagnosis and initial treatment of transplant‐eligible high‐risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 833, doi. 10.1111/bjh.19623
- By:
- Publication type:
- Article
Body‐wide chimerism and mosaicism are predominant causes of naturally occurring ABO discrepancies.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1188, doi. 10.1111/bjh.19618
- By:
- Publication type:
- Article
Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1197, doi. 10.1111/bjh.19633
- By:
- Publication type:
- Article
Efficacy of thrombopoietin receptor agonists versus rituximab in non‐responsive immune thrombocytopenia—A single centre retrospective analysis.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1121, doi. 10.1111/bjh.19629
- By:
- Publication type:
- Article
Azacitidine combined with interferon‐α for pre‐emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1067, doi. 10.1111/bjh.19628
- By:
- Publication type:
- Article
Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real‐world evidence.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 780, doi. 10.1111/bjh.19627
- By:
- Publication type:
- Article
A pharmacokinetic–pharmacodynamic analysis of l‐glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapy.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1147, doi. 10.1111/bjh.19632
- By:
- Publication type:
- Article
Effect of peptide‐binding motif on survival of HLA‐haploidentical transplantation with post‐transplant cyclophosphamide.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1077, doi. 10.1111/bjh.19630
- By:
- Publication type:
- Article
A novel scoring model for predicting efficacy and guiding individualised treatment in immune thrombocytopaenia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1108, doi. 10.1111/bjh.19615
- By:
- Publication type:
- Article
Monitoring molecular changes in the management of myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 772, doi. 10.1111/bjh.19614
- By:
- Publication type:
- Article
Large B‐cell lymphoma with mystery rearrangement: Applying Hi‐C to the detection of clinically relevant structural abnormalities.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1225, doi. 10.1111/bjh.19611
- By:
- Publication type:
- Article
Increased myeloid‐derived suppressor cell activation in clonal cytopenia of undetermined significance and low‐risk myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1220, doi. 10.1111/bjh.19609
- By:
- Publication type:
- Article
CD19‐CAR T‐cell therapy with sorafenib in post‐HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch—A case report and review of the literature.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1215, doi. 10.1111/bjh.19608
- By:
- Publication type:
- Article
Long‐lasting autoimmune neutropenia and GFI1 variant: A case of familial inheritance.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1212, doi. 10.1111/bjh.19606
- By:
- Publication type:
- Article
Relevance of repeated analyses of albuminuria and glomerular filtration rate in African children with sickle cell anaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1137, doi. 10.1111/bjh.19603
- By:
- Publication type:
- Article
Successful treatment of relapsed idiopathic multicentric Castleman disease–idiopathic plasmacytic lymphadenopathy with orelabrutinib monotherapy: A case report.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1208, doi. 10.1111/bjh.19596
- By:
- Publication type:
- Article
Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1011, doi. 10.1111/bjh.19595
- By:
- Publication type:
- Article
Response adaptive salvage treatment with daratumumab–lenalidomide–dexamethasone for newly diagnosed transplant‐eligible multiple myeloma patients failing front‐line bortezomib‐based induction therapy—ALLG MM21.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 900, doi. 10.1111/bjh.19578
- By:
- Publication type:
- Article
Twice‐weekly induction with ixazomib–lenalidomide–dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant‐eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014‐03
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 891, doi. 10.1111/bjh.19570
- By:
- Publication type:
- Article
Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1202, doi. 10.1111/bjh.19569
- By:
- Publication type:
- Article
Ras‐associated autoimmune lymphoproliferative disorder.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 819, doi. 10.1111/bjh.19564
- By:
- Publication type:
- Article
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 881, doi. 10.1111/bjh.19555
- By:
- Publication type:
- Article
Gilteritinib with or without venetoclax for relapsed/refractory FLT3‐mutated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 932, doi. 10.1111/bjh.19548
- By:
- Publication type:
- Article
Inflammatory profile of lower risk myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 1044, doi. 10.1111/bjh.19530
- By:
- Publication type:
- Article
Pregnancy and childbirth in patients with Glanzmann Thrombasthenia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 815, doi. 10.1111/bjh.19528
- By:
- Publication type:
- Article
Prognostic factors of idiopathic hypereosinophilic syndrome: A nationwide survey in Japan.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 967, doi. 10.1111/bjh.19527
- By:
- Publication type:
- Article
Changes in T‐cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T‐cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 999, doi. 10.1111/bjh.19515
- By:
- Publication type:
- Article
The Menin story in acute myeloid leukaemia—The road to success.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 812, doi. 10.1111/bjh.19508
- By:
- Publication type:
- Article
French early nationwide idecabtagene vicleucel chimeric antigen receptor T‐cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real‐world IFM study from the DESCAR‐T registry.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 990, doi. 10.1111/bjh.19505
- By:
- Publication type:
- Article